Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2015-09-14 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于2015年第三次临时股东大会增加临时提案的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement regarding the addition of a temporary proposal to the agenda of the company's 2015 third extraordinary general meeting of shareholders. It includes details about the meeting date, voting procedures, and the specific proposals to be voted on, such as the issuance of short-term financing bonds and the appointment of a supervisor. The document does not contain financial statements or detailed financial analysis but is focused on shareholder meeting logistics and proposals. It is not a full report but an announcement related to a shareholder meeting and voting matters. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it pertains to shareholder voting proposals and meeting information.
2015-09-14 Chinese
关于申请发行短期融资券的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company 中源协和细胞基因工程股份有限公司 regarding its plan to apply for the issuance of short-term financing bonds (短期融资券). It details the issuance plan, including amount, issuance date, term, interest rate, underwriting method, and authorization matters related to the issuance. There are no financial statements or detailed financial performance data included. The document is clearly an announcement about a capital raising activity, specifically the issuance of short-term financing bonds, which fits the category of Capital/Financing Update (CAP). The document length is short (1130 characters), but it contains substantive information about the financing plan rather than just announcing a report publication or providing a link. Therefore, it should be classified as CAP with high confidence.
2015-09-14 Chinese
债务融资工具的信息披露事务管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for information disclosure related to debt financing instruments of a company. It contains detailed internal rules, responsibilities, procedures, and standards for information disclosure, including chapters on general provisions, disclosure content and standards, management of disclosure affairs, confidentiality measures, financial management and internal control, and communication with investors and media. There are no financial statements, audit reports, earnings data, or direct financial results presented. Instead, it is a governance and procedural document outlining how the company manages disclosure of information, especially related to debt financing. This fits the description of a Governance Information report, which details internal rules, board structure, and governance practices related to information disclosure.
2015-09-14 Chinese
第八届董事会第三十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from 中源协和细胞基因工程股份有限公司, detailing decisions made by the board regarding the application for issuing short-term financing bonds and the establishment of an information disclosure management system for debt financing instruments. It includes voting results and references to further announcements. The content focuses on board decisions and governance matters rather than financial results, audit, or regulatory filings. It is not a full report but a formal announcement of board resolutions. Therefore, it fits best under Board/Management Information (MANG). The document length is short and does not contain financial statements or detailed financial data, so it is not an Annual Report or Interim Report.
2015-09-14 Chinese
第八届董事会第二十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement from the board of directors of a company regarding the appointment of a new Chief Financial Officer (CFO) and related board matters. It includes details about the resignation of the previous CFO, the qualifications of the new CFO, and the voting results of the board meeting. There is also mention of a resolution to convene a shareholders' meeting. The document does not contain financial statements, earnings data, or detailed financial analysis. It is focused on management changes and board decisions. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (1322 characters), and it is not a report publication announcement or a certification. Hence, the classification is MANG with high confidence.
2015-09-10 Chinese
第八届监事会第八次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of a resolution from the company's supervisory board meeting regarding the appointment of a new supervisor to the board. It includes details about the meeting, voting results, and a brief biography of the appointed individual. There are no financial statements, audit results, or detailed financial data presented. The document is focused on board/management changes, specifically the addition of a new supervisor due to a resignation. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS.
2015-09-10 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.